Table 1.
Patient Demographics and Clinical Characteristics
| Demographic or Clinical Characteristic | No. of Patients (N = 3,927) | % |
|---|---|---|
| Age, years | ||
| < 55 | 287 | 7.3 |
| 55-64 | 1,476 | 37.6 |
| 65-80 | 1,725 | 43.9 |
| > 80 | 439 | 11.2 |
| Male | 3,842 | 97.8 |
| Race | ||
| White | 3,255 | 82.9 |
| Black | 595 | 15.2 |
| Other/unknown | 77 | 2.0 |
| Married/living with partner | 1,874 | 47.7 |
| Rural residence | 1,137 | 29.0 |
| NSCLC stage | ||
| I | 768 | 22.0 |
| II | 679 | 19.4 |
| III | 993 | 28.4 |
| IV | 1,053 | 30.1 |
| SCLC | ||
| Limited disease | 157 | 36.2 |
| Extensive disease | 239 | 55.1 |
| Unknown | 38 | 8.8 |
| Poor performance status | 553 | 14.1 |
| Medical oncology consultation | 1,933 | 49.2 |
| Death during study period | 2,573 | 65.5 |
| Comorbidity level* | ||
| None | 200 | 13.8 |
| Mild | 509 | 35.2 |
| Moderate | 352 | 24.3 |
| Severe | 386 | 26.7 |
| Severe pulmonary disease* | 285 | 19.7 |
| Surgery consultation* | 1,192 | 82.4 |
Abbreviations: NSCLC, non–small-cell lung cancer; SCLC, small-cell lung cancer.
*
Data collected only for patients with stage I and II NSCLC.